Searching for Better Detection: The 'Holy Grail' of Ovarian Cancer
Researchers are on the hunt for a better biomarker in ovarian cancer that could detect the disease in earlier stages.
BY BRIELLE URCIUOLI
PUBLISHED JULY 25, 2018
While survival rates among patients with ovarian cancer have increased in recent years thanks to newer and more personalized treatment approaches – including the groundbreaking addition of PARP inhibitors – one major question still remains: How can the disease be detected in its earlier stages?